Evidence map›Paper›PMID 40195702›Full record

ReviewRecent advances in inflammation & allergy drug discovery2025

Unveiling Psoriasis: Delving into Pathogenesis, Treatment Breakthroughs, and Patent Trends.

Azad Kumar Maurya, Dharmendra Jain

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent advances in inflammation & allergy drug discovery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Azad Kumar MauryaDepartment of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar (M.P.), Pin Code, 470003, India.ORCID 0009-0000-6788-0995
Dharmendra JainDepartment of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya, Sagar (M.P.), Pin Code, 470003, India.ORCID 0000-0002-2528-2935

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the world, millions of individuals suffer from psoriasis, a chronic inflammatory skin disease. It is caused by a multifaceted mixture of environmental, immunological, and genetic factors. This review explores the many aspects of psoriasis, where the introduction gives a context background, emphasizing the prevalence and difficulties that people encounter with this dermatological ailment. Further, the pathogenesis complex systems involving immunological dysregulation, genetic susceptibility, and triggers are clarified, providing insights into the disease's fundamental mechanisms. Examining drugs shows how, over time, therapy modalities have evolved, moving from traditional topical treatments to the introduction of biologics and small molecules. The continuous efforts to control symptoms, reduce inflammation, and improve patient outcomes are highlighted in this section. Furthermore, a thorough review of patents reveals the creative advancements made in the sector, highlighting encouraging advancements in treatment modalities and potential paths forward. This manuscript is a review article and is based on various research and review articles. We have summarized the salient features and findings from different articles and prepared this manuscript.

Indexed as

Biological ProductsDermatologic AgentsPsoriasisAnimalsGenetic Predisposition to DiseaseHumansPatents as TopicBiological ProductsDermatologic Agentsautoimmune disorderbiologicschronic skin diseasePsoriasisT-cells.topical treatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.